Comets and shooting stars /

Includes index.

Duck fleas as evidence for eiderdown production on archaeological sites

Acknowledgements This project was undertaken as part of my doctoral studies funded by the Commonwealth Scholarship Commission (CACR-2009-39) in the United Kingdom. I would like to thank my supervisors Karen Milek and Andrew Dugmore for their help and support. I also wish to thank Jónas Helgason, his son Alexius Jónasson and Baldur Vilhelmsson for kindly having allowed access to the eiderdown stores and workshops at Æðey and Vatnsfjörður and for having provided assistance when needed. I would like to thank Fornleifastofnun Íslands for supporting my fieldwork at Vatnsfjörður, as well as Paul Ledger and Garðar Guðmundsson for their help during fieldwork. I am especially grateful to Richard Marriott for his invaluable help with flea identifications and for lending me reference material. Erling Ólafsson and Jan Klimaszewski also helped with the beetle identifications. Consultation of the BugsCEP database (Buckland and Buckland, 2006) aided the redaction of this paper.

Duck fleas as evidence for eiderdown production on archaeological sites

Acknowledgements This project was undertaken as part of my doctoral studies funded by the Commonwealth Scholarship Commission (CACR-2009-39) in the United Kingdom. I would like to thank my supervisors Karen Milek and Andrew Dugmore for their help and support. I also wish to thank Jónas Helgason, his son Alexius Jónasson and Baldur Vilhelmsson for kindly having allowed access to the eiderdown stores and workshops at Æðey and Vatnsfjörður and for having provided assistance when needed. I would like to thank Fornleifastofnun Íslands for supporting my fieldwork at Vatnsfjörður, as well as Paul Ledger and Garðar Guðmundsson for their help during fieldwork. I am especially grateful to Richard Marriott for his invaluable help with flea identifications and for lending me reference material. Erling Ólafsson and Jan Klimaszewski also helped with the beetle identifications. Consultation of the BugsCEP database (Buckland and Buckland, 2006) aided the redaction of this paper.

Duck fleas as evidence for eiderdown production on archaeological sites

Acknowledgements This project was undertaken as part of my doctoral studies funded by the Commonwealth Scholarship Commission (CACR-2009-39) in the United Kingdom. I would like to thank my supervisors Karen Milek and Andrew Dugmore for their help and support. I also wish to thank Jónas Helgason, his son Alexius Jónasson and Baldur Vilhelmsson for kindly having allowed access to the eiderdown stores and workshops at Æðey and Vatnsfjörður and for having provided assistance when needed. I would like to thank Fornleifastofnun Íslands for supporting my fieldwork at Vatnsfjörður, as well as Paul Ledger and Garðar Guðmundsson for their help during fieldwork. I am especially grateful to Richard Marriott for his invaluable help with flea identifications and for lending me reference material. Erling Ólafsson and Jan Klimaszewski also helped with the beetle identifications. Consultation of the BugsCEP database (Buckland and Buckland, 2006) aided the redaction of this paper.

Shooting for the Moon or Flying Too Near the Sun? Crossing the Value Rubicon in Precision Cancer Care

In his last two State of the Union addresses, President Barack Obama has focused on the need to deliver innovative solutions to improve human health, through the Precision Medicine Initiative in 2015 and the recently announced Cancer Moonshot in 2016. Precision cancer care has delivered clear patient benefit, but even for high-impact medicines such as imatinib mesylate (Glivec) in chronic myeloid leukaemia, the excitement at the success of this practice-changing clinical intervention has been somewhat tempered by the escalating price of this 'poster child' for precision cancer medicine (PCM). Recent studies on the costs of cancer drugs have revealed significant price differentials, which are a major causative factor behind disparities in the access to new generations of immunological and molecularly targeted agents. In this perspective, we will discuss the benefits of PCM to modern cancer control, but also emphasise how increasing costs are rendering the current approaches to integrating the paradigm of PCM unsustainable. Despite the ever increasing pressure on cancer and health care budgets, innovation will and must continue. Value-based frameworks offer one of the most rational approaches for policymakers committed to improving cancer outcomes through a public health approach.